These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 20957078)

  • 1. Mitochondria and neuroplasticity.
    Cheng A; Hou Y; Mattson MP
    ASN Neuro; 2010 Oct; 2(5):e00045. PubMed ID: 20957078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.
    Yan MH; Wang X; Zhu X
    Free Radic Biol Med; 2013 Sep; 62():90-101. PubMed ID: 23200807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass.
    Uittenbogaard M; Baxter KK; Chiaramello A
    ASN Neuro; 2010 May; 2(2):e00034. PubMed ID: 20517466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.
    Raefsky SM; Mattson MP
    Free Radic Biol Med; 2017 Jan; 102():203-216. PubMed ID: 27908782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF-induced local protein synthesis and synaptic plasticity.
    Leal G; Comprido D; Duarte CB
    Neuropharmacology; 2014 Jan; 76 Pt C():639-56. PubMed ID: 23602987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial complex I as a therapeutic target for Alzheimer's disease.
    Trushina E; Trushin S; Hasan MF
    Acta Pharm Sin B; 2022 Feb; 12(2):483-495. PubMed ID: 35256930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.
    Kumar S; Reddy AP; Yin X; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2428-2440. PubMed ID: 31181293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of drug-based neuroprotection targeting mitochondria.
    Procaccio V; Bris C; Chao de la Barca JM; Oca F; Chevrollier A; Amati-Bonneau P; Bonneau D; Reynier P
    Rev Neurol (Paris); 2014 May; 170(5):390-400. PubMed ID: 24792485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria in neuroplasticity and neurological disorders.
    Mattson MP; Gleichmann M; Cheng A
    Neuron; 2008 Dec; 60(5):748-66. PubMed ID: 19081372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate and neurotrophic factors in neuronal plasticity and disease.
    Mattson MP
    Ann N Y Acad Sci; 2008 Nov; 1144():97-112. PubMed ID: 19076369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.
    Nakamura T; Lipton SA
    Apoptosis; 2010 Nov; 15(11):1354-63. PubMed ID: 20177970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial regulation of neuronal plasticity.
    Mattson MP
    Neurochem Res; 2007; 32(4-5):707-15. PubMed ID: 17024568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shaping synaptic plasticity: the role of activity-mediated epigenetic regulation on gene transcription.
    Cortés-Mendoza J; Díaz de León-Guerrero S; Pedraza-Alva G; Pérez-Martínez L
    Int J Dev Neurosci; 2013 Oct; 31(6):359-69. PubMed ID: 23665156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.
    Calkins MJ; Manczak M; Mao P; Shirendeb U; Reddy PH
    Hum Mol Genet; 2011 Dec; 20(23):4515-29. PubMed ID: 21873260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.
    Turner PR; O'Connor K; Tate WP; Abraham WC
    Prog Neurobiol; 2003 May; 70(1):1-32. PubMed ID: 12927332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.